Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial

INTRODUCTION: Upfront surgeries are not beneficial to most patients with pancreatic cancer. Therefore, more emphasis has been placed chemoradiotherapy in locally advanced pancreatic cancer recently. Gemcitabine-based regimens or FOLFIRINOX (a chemotherapy regimen including leucovorin, 5-FU, irinotec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaofei, Ju, Xiaoping, Cao, Fei, Fang, Fang, Qing, Shuiwang, Shen, Yuxin, Jia, Zhen, Cao, Yangsen, Zhang, Huojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168617/
https://www.ncbi.nlm.nih.gov/pubmed/27909037
http://dx.doi.org/10.1136/bmjopen-2016-013220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168617/
https://www.ncbi.nlm.nih.gov/pubmed/27909037
http://dx.doi.org/10.1136/bmjopen-2016-013220

Ejemplares similares